HC Wainwright Cuts Vor Biopharma (NYSE:VOR) Price Target to $13.00
Vor Biopharma (NYSE:VOR – Free Report) had its price objective trimmed by HC Wainwright from $17.50 to $13.00 in a research note published on Friday,Benzinga reports. The firm currently has a buy rating on the stock. A number of other analysts also recently issued reports on VOR. Wedbush restated an “outperform” rating and set a […]
Vor Biopharma (NYSE:VOR – Free Report) had its price objective trimmed by HC Wainwright from $17.50 to $13.00 in a research note published on Friday,Benzinga reports. The firm currently has a buy rating on the stock. A number of other analysts also recently issued reports on VOR. Wedbush restated an “outperform” rating and set a […]
-logo.PNG?v=20210211152200&w=240&h=240&zc=2){kind=logo}
